IM Cannabis Corp. (NASDAQ:IMCC ) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Operator Good morning, and welcome to IM Cannabis' First Quarter 2025 Earnings Conference Call. Today's conference call is being recorded.
IM Cannabis Corp. (NASDAQ:IMCC ) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Operator Good morning and welcome to IM Cannabis' Fourth Quarter and Full Year 2024 Earnings Conference Call. Today's conference call is being recorded.
IM Cannabis Corp. (NASDAQ:IMCC ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Operator Good morning, and welcome to IM Cannabis' Third Quarter 2024 Earnings Conference Call. Today's conference call is being recorded.
| Specialty Retail Industry | Consumer Discretionary Sector | Oren Shuster CEO | NASDAQ (CM) Exchange | 44969Q208 CUSIP |
| IL Country | 95 Employees | - Last Dividend | 12 Jul 2024 Last Split | - IPO Date |
IM Cannabis Corp. is a distinguished entity within the medical and recreational cannabis industry, with operations spanning across Israel, Germany, and Canada. It primarily focuses on the breeding, growing, and supplying of premium medical cannabis products. Emphasizing quality and accessibility, the company operates under the IMC brand, which has gained significant recognition for its exceptional cannabis flowers and strain-specific cannabis extracts. Headquartered in Tel Aviv-Yafo, Israel, IM Cannabis Corp. caters to a broad array of consumers, encompassing both medical patients and individuals seeking cannabis for adult recreational use.